Globus Medical

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Globus Medical and other ETFs, options, and stocks.

About GMED

Globus Medical, Inc. operates as a medical device company that develops and commercializes healthcare solutions. It engages in developing products that promote healing in patients with musculoskeletal disorders. 

CEO
Keith W. Pfeil
CEOKeith W. Pfeil
Employees
6,000
Employees6,000
Headquarters
Audubon, Pennsylvania
HeadquartersAudubon, Pennsylvania
Founded
2003
Founded2003
Employees
6,000
Employees6,000

GMED Key Statistics

Market cap
11.57B
Market cap11.57B
Price-Earnings ratio
21.60
Price-Earnings ratio21.60
Dividend yield
Dividend yield
Average volume
990.47K
Average volume990.47K
High today
$86.38
High today$86.38
Low today
$85.35
Low today$85.35
Open price
$86.02
Open price$86.02
Volume
95.52K
Volume95.52K
52 Week high
$101.40
52 Week high$101.40
52 Week low
$51.79
52 Week low$51.79

Stock Snapshot

As of today, Globus Medical(GMED) shares are valued at $85.70. The company's market cap stands at 11.57B, with a P/E ratio of 21.60.

On 2026-03-16, Globus Medical(GMED) stock moved within a range of $85.35 to $86.38. With shares now at $85.70, the stock is trading +0.4% above its intraday low and -0.8% below the session's peak.

Trading activity shows a volume of 95.52K, compared to an average daily volume of 990.47K.

The stock's 52-week range extends from a low of $51.79 to a high of $101.40.

The stock's 52-week range extends from a low of $51.79 to a high of $101.40.

GMED News

Simply Wall St 2d
Is It Time To Reassess Globus Medical After Strong Multi Year Share Price Gains

Wondering whether Globus Medical's current share price lines up with its underlying value, or if the market is missing something important. The stock recently...

Is It Time To Reassess Globus Medical After Strong Multi Year Share Price Gains
Simply Wall St 4d
Assessing Globus Medical Valuation After Hammer Pattern Signal And Upgraded Earnings Outlook

Advertisement Technical signal and earnings expectations shift focus to Globus Medical A recent hammer chart pattern in Globus Medical (GMED) has coincided wi...

Assessing Globus Medical Valuation After Hammer Pattern Signal And Upgraded Earnings Outlook
Nasdaq 6d
National Vision Gains 129.5% in a Year: What's Driving the Rally?

National Vision EYE has witnessed strong momentum over the past year. Shares of the company have risen 129.5%, outperforming the industry’s 12% decline. The S&P...

National Vision Gains 129.5% in a Year: What's Driving the Rally?

Analyst ratings

71%

of 17 ratings
Buy
70.6%
Hold
29.4%
Sell
0%

More GMED News

Simply Wall St 7d
Globus Medical Weighs Future Deals Against Product And Integration Spending

Globus Medical (NYSE:GMED) has signaled plans to pursue additional acquisitions that complement its existing portfolio. The company also highlighted increased...

Globus Medical Weighs Future Deals Against Product And Integration Spending

People also own

Based on the portfolios of people who own GMED. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.